New Argonaut Project is collaborative effort to drive FHIR standard

Health Level Seven (HL7) has launched the Argonaut Project, a collaborative initiative that aims to address the recommendations of the JASON Task Force.

The project, which includes big names such as Epic, Cerner, Mayo Clinic, Intermountain and Partners HealthCare, has a goal of accelerating the development and adoption of HL7’s standards framework, FHIR--Fast Healthcare Interoperability Resources.

FHIR is billed as a next-generation framework that makes use of the latest Web-based standards, with a focus on putting them to work in healthcare interoperability. HL7 officials say FHIR is a so-called "RESTful" application programming interface -- an approach that's based on modern Internet conventions and is commonly deployed in other industries.

FHIR is a "next generation standards framework that leverages the latest web standards and applies a tight focus on implementation," according to a release from the organization. "FHIR represents a signficant advance in accessing and delivering data while offering enormous flexibility."

“Our national health IT policy has always focused on the adoption of private sector-led standards,” said Aneesh Chopra, former U.S. chief technology officer, in a release about the Argonaut Project. “Today’s acceleration initiative draws on that collaborative spirit and will translate into better technologies to support better healthcare for patients and providers.”

The Argonaut Project aims to quickly develop a first-generation FHIR-based API and core data services specification to enable expanded information sharing for EHRs and other health IT based on Internet standards and architectural patterns and style, say HL7 officials. The project will accelerate current FHIR development efforts to provide practical and focused FHIR profiles and implementation guides to the industry by the spring of 2015.

"FHIR is already being tested and implemented by leading organizations in the public, private and academic communities," said HL7 CEO Charles Jaffe, MD, in a press statement. "We believe this will drive industry-wide adoption. If you make something useful, people will embrace it."

JASON Task Force co-chair Micky Tripathi, CEO and president of the Massachusetts eHealth Collaborative, has committed his organization to serve as the project manager for this initiative. The project "shows that private industry is now able to collectively and collaboratively play the lead role in rationalizing and modernizing nationwide healthcare interoperability, just as it has in other sectors of the economy," he said in the release.

"In 2014, there has been a perfect storm of alignment among government, industry, academia, provider organizations and innovators that FHIR is our best opportunity to accelerate interoperability," said HIT Standards Committee Co-Chair and Beth Israel Deaconess Medical Center CIO John Halamka, MD, in a statement.

"At this point in history we have an unprecedented opportunity to apply additional resources and focus, producing a simple, consensus-based implementation guide for query/response transactions in healthcare using the same type of technologies that Facebook, Google, and Amazon have already implemented at scale," said Halamka. "We are not creating a new organization to do this work; instead we are all unifying around HL7 as an ANSI-accredited standards development organization to deliver what we all need.”

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.